
Cholesterol-lowering drug slows progression of eye disease in people with diabetes
Published on June 20, 2024
The LENS trial has demonstrated that fenofibrate, a drug usually used to lower cholesterol, reduces the risk of progression of diabetic retinopathy by 27%. The results were announced today at the American Diabetes Association Scientific Sessions and published in NEJM Evidence.
